News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
395,021 Results
Type
Article (15911)
Company Profile (193)
Press Release (378912)
Multimedia
Podcasts (51)
Webinars (9)
Section
Business (116499)
Career Advice (459)
Deals (19258)
Drug Delivery (41)
Drug Development (36424)
Employer Resources (51)
FDA (9143)
Job Trends (7981)
News (182192)
Policy (12929)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1416)
Academic (1)
Accelerated approval (11)
Adcomms (1)
Allergies (75)
Alliances (35805)
ALS (72)
Alzheimer's disease (814)
Antibody-drug conjugate (ADC) (189)
Approvals (9344)
Artificial intelligence (451)
Autoimmune disease (73)
Automation (33)
Bankruptcy (133)
Best Places to Work (6811)
BIOSECURE Act (7)
Biosimilars (32)
Biotechnology (122)
Bladder cancer (64)
Brain cancer (30)
Breast cancer (290)
Cancer (2420)
Cardiovascular disease (160)
Career advice (418)
Career pathing (9)
CAR-T (203)
CDC (8)
Celiac Disease (1)
Cell therapy (508)
Cervical cancer (21)
Clinical research (30334)
Collaboration (1277)
Compensation (285)
Complete response letters (13)
COVID-19 (1301)
CRISPR (85)
C-suite (506)
Cystic fibrosis (113)
Data (3162)
Decentralized trials (1)
Denatured (27)
Depression (71)
Diabetes (238)
Diagnostics (5186)
Digital health (36)
Diversity (8)
Diversity, equity & inclusion (9)
Drug discovery (173)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (99)
Earnings (42499)
Editorial (10)
Employer branding (8)
Employer resources (45)
Events (57408)
Executive appointments (590)
FDA (10884)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (964)
Gene editing (171)
Generative AI (38)
Gene therapy (359)
GLP-1 (343)
Government (1339)
Grass and pollen (3)
Guidances (234)
Healthcare (10312)
HIV (23)
Huntington's disease (21)
IgA nephropathy (46)
Immunology and inflammation (93)
Immuno-oncology (22)
Indications (54)
Infectious disease (1446)
Inflammatory bowel disease (100)
Inflation Reduction Act (5)
Influenza (76)
Intellectual property (176)
Interviews (53)
IPO (8475)
IRA (10)
Job creations (1467)
Job search strategy (365)
JPM (21)
Kidney cancer (6)
Labor market (24)
Layoffs (143)
Leadership (7)
Legal (2566)
Liver cancer (47)
Longevity (8)
Lung cancer (260)
Lymphoma (184)
Machine learning (34)
Management (18)
Manufacturing (529)
MASH (46)
Medical device (11899)
Medtech (11948)
Mergers & acquisitions (11439)
Metabolic disorders (478)
Multiple sclerosis (88)
NASH (6)
Neurodegenerative disease (148)
Neuropsychiatric disorders (44)
Neuroscience (1468)
NextGen: Class of 2026 (3659)
Non-profit (1599)
Now hiring (15)
Obesity (180)
Opinion (103)
Ovarian cancer (109)
Pain (122)
Pancreatic cancer (123)
Parkinson's disease (158)
Partnered (21)
Patents (326)
Patient recruitment (272)
Peanut (32)
People (34741)
Pharmaceutical (36)
Pharmacy benefit managers (3)
Phase 1 (11051)
Phase 2 (13930)
Phase 3 (8720)
Pipeline (2897)
Policy (60)
Postmarket research (562)
Preclinical (5033)
Press Release (66)
Prostate cancer (106)
Psychedelics (6)
Radiopharmaceuticals (181)
Rare diseases (374)
Real estate (3431)
Recruiting (22)
Regulatory (10975)
Reports (20)
Research institute (1365)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (11)
RSV (40)
Schizophrenia (69)
Series A (175)
Series B (119)
Service/supplier (10)
Sickle cell disease (36)
Special edition (1)
Spinal muscular atrophy (81)
Sponsored (30)
Startups (2613)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (509)
Venture capital (45)
Weight loss (63)
Women's health (47)
Worklife (2)
Date
Today (8)
Last 7 days (302)
Last 30 days (1231)
Last 365 days (16258)
2026 (1543)
2025 (16593)
2024 (20407)
2023 (23786)
2022 (32657)
2021 (34429)
2020 (32322)
2019 (26914)
2018 (20244)
2017 (19801)
2016 (18539)
2015 (21424)
2014 (15747)
2013 (13114)
2012 (14123)
2011 (14495)
2010 (13229)
Location
Africa (329)
Alabama (69)
Alaska (6)
Arizona (180)
Arkansas (10)
Asia (25530)
Australia (4473)
California (5958)
Canada (1782)
China (575)
Colorado (323)
Connecticut (248)
Delaware (119)
Europe (53827)
Florida (1007)
Georgia (246)
Hawaii (2)
Idaho (41)
Illinois (486)
India (35)
Indiana (275)
Iowa (10)
Japan (280)
Kansas (101)
Kentucky (18)
Louisiana (19)
Maine (24)
Maryland (772)
Massachusetts (4252)
Michigan (275)
Minnesota (419)
Mississippi (5)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (66)
New Hampshire (83)
New Jersey (1639)
New Mexico (20)
New York (1602)
North Carolina (780)
North Dakota (9)
Northern California (2569)
Ohio (172)
Oklahoma (16)
Oregon (25)
Pennsylvania (1078)
Puerto Rico (19)
Rhode Island (38)
South America (519)
South Carolina (60)
South Dakota (1)
Southern California (2527)
Tennessee (105)
Texas (955)
United States (21894)
Utah (204)
Vermont (1)
Virginia (110)
Washington D.C. (22)
Washington State (571)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
395,021 Results for "axonics modulation technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Axon Neuroscience’s Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant
February 4, 2026
·
6 min read
Press Releases
Axon Therapies Raises $32M in Oversubscribed Series A to Transform Heart Failure Treatment
September 25, 2025
·
3 min read
Press Releases
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
February 5, 2026
·
7 min read
Press Releases
Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity
January 27, 2026
·
4 min read
Press Releases
Dewpoint Therapeutics Announces TDP-43 Condensate Modulator Development Candidate for Treatment of ALS and Related Neurodegenerative Diseases
January 9, 2026
·
3 min read
Press Releases
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
February 3, 2026
·
6 min read
Press Releases
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
January 5, 2026
·
5 min read
Press Releases
Talus Bio Announces New Collaboration with PRISM BioLab to Discover Novel Modulators of Transcription Factor and Protein-Protein Interaction Targets
December 18, 2025
·
4 min read
Press Releases
Cognixion and Blackrock Neurotech Expand Access to Non-Invasive, Multi-Modal BCI Research with Axon-R
May 14, 2025
·
4 min read
Deals
Axonics Stockholders Approve Merger Agreement with Boston Scientific
Axonics, Inc. announced that its stockholders have voted to adopt Axonics’ merger agreement with Boston Scientific Corporation.
March 22, 2024
·
5 min read
1 of 39,503
Next
